Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.13 CHF | +0.77% | -1.40% | -6.93% |
Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Sales 2023 * | 8.29M 9.12M | Sales 2024 * | 51.09M 56.22M | Capitalization | 103M 114M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 12.5 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2.02 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 46 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.76% |
Latest transcript on Santhera Pharmaceuticals Holding AG
1 day | +0.77% | ||
1 week | -1.40% | ||
Current month | -1.40% | ||
1 month | -4.10% | ||
3 months | -4.99% | ||
6 months | -18.04% | ||
Current year | -6.93% |
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 19-11-30 |
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Andrew P. Smith
DFI | Director of Finance/CFO | 61 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Director/Board Member | 56 | 17-04-03 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 23-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 9.13 | +0.77% | 15,216 |
24-05-06 | 9.06 | -2.69% | 42,492 |
24-05-03 | 9.31 | -0.64% | 21,042 |
24-05-02 | 9.37 | +1.19% | 18,571 |
24-04-30 | 9.26 | -1.70% | 14,687 |
Delayed Quote Swiss Exchange, May 07, 2024 at 11:31 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.93% | 113M | |
+6.52% | 71.18B | |
+13.33% | 9.23B | |
-11.55% | 5B | |
+48.05% | 4.46B | |
+5.09% | 3.95B | |
-14.74% | 2.54B | |
+20.00% | 2.44B | |
-24.89% | 2.36B | |
+21.45% | 2.18B |
- Stock Market
- Equities
- SANN Stock